当前位置: X-MOL 学术Emerg. Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022
Emerging Infectious Diseases ( IF 11.8 ) Pub Date : 2024-03-18 , DOI: 10.3201/eid3004.231361
Farrell A. Tobolowsky , Fred Nsubuga , Zunera Gilani , Annet Kisakye , Helen Ndagije , Daniel Kyabayinze , Jane F. Gidudu

Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine. No safety signals were identified using a multipronged approach of passive and active surveillance.



中文翻译:

新型口服脊髓灰质炎病毒疫苗 2 号在全国补充免疫活动期间的安全性评估,乌干达,2022 年

鉴于其增强的遗传稳定性,新型口服 2 型脊髓灰质炎病毒疫苗被用于世界卫生组织紧急使用清单下的 2 型脊髓灰质炎病毒爆发应对。我们评估了该疫苗的安全性。使用被动和主动监测的多管齐下方法没有发现任何安全信号。

更新日期:2024-03-19
down
wechat
bug